Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus

Helena Enocsson*, Lina Wirestam, Charlotte Dahle, Leonid Padyukov, Andreas Jönsen, Murray B. Urowitz, Dafna D. Gladman, Juanita Romero-Diaz, Sang Cheol Bae, Paul R. Fortin, Jorge Sanchez-Guerrero, Ann E. Clarke, Sasha Bernatsky, Caroline Gordon, John G. Hanly, Daniel J. Wallace, David A. Isenberg, Anisur Rahman, Joan T. Merrill, Ellen GinzlerGraciela S. Alarcón, W. Winn Chatham, Michelle Petri, Munther Khamashta, Cynthia Aranow, Meggan Mackay, Mary Anne Dooley, Susan Manzi, Rosalind Ramsey-Goldman, Ola Nived, Kristjan Steinsson, Asad A. Zoma, Guillermo Ruiz-Irastorza, S. Sam Lim, Kenneth C. Kalunian, Murat Inanc, Ronald F. van Vollenhoven, Manuel Ramos-Casals, Diane L. Kamen, Søren Jacobsen, Christine A. Peschken, Anca Askanase, Thomas Stoll, Ian N. Bruce, Jonas Wetterö, Christopher Sjöwall

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus'. Together they form a unique fingerprint.

Medicine & Life Sciences